| Giberellic Acid, OX7-SAP (pan-neural), Custom Conjugations, and Chick-ZAP reducing agent |
Targeting Trends, Q2-2012 |
| Blocking NGFr and Using fluorescence |
Targeting Trends, Q1-2012 |
| Choosing the Secondary Conjugate |
Targeting Trends, Q4-2011 |
| Secondary Conjugates, Negative Charge, Protocols |
Targeting Trends, Q3-2011 |
| Customs, Conjugates, and Toxicity |
Targeting Trends, Q2-2011 |
GAT1-SAP; Hippocampal Neurons;
IgM Controls & Secondary Conjugates |
Targeting Trends, Q1-2011 |
| Immunotoxin Tracers |
Targeting Trends, Q4-2010 |
| Fab-ZAP protocol and toxicity |
Targeting Trends, Q3-2010 |
| Testing lots of Orexin-SAP |
Targeting Trends, Q2-2010 |
| Lot-to-lot variation; Secondary Conjugates;
Saporin activity |
Targeting Trends, Q1-2010 |
| Anti-Melanopsin Immunostaining Protocol |
Targeting Trends, Q3-2009 |
| Product Questions |
Targeting Trends, Q2-2009 |
| Anti-IgM-ZAP (Anti-M-ZAP) |
Targeting Trends, Q1-2009 |
| Saporin Clearance |
Targeting Trends, Q4-2008 |
| Apoptosis or Necrosis? |
Targeting Trends, Q3-2008 |
| Cytotoxicity Assay Protocols |
Targeting Trends, Q2-2008 |
| Secondary Conjugates; Reducing Agents |
Targeting Trends, Q1-2008 |
| Cost of Targeted Toxin |
Targeting Trends, Q4-2007 |
Disposal, Sterilization, Intrastriatal
Administration, and Activation |
Targeting Trends, Q3-2007 |
| Agonist Effects |
Targeting Trends, Q2-2007 |
| Targeted Toxin Controls |
Targeting Trends, Q1-2007 |
| Anti-DBH-SAP Administration |
Targeting Trends, Q4-2006 |
| Retrograde Transport |
Targeting Trends, Q2/Q3-2006 .. |
| LPS Content |
Targeting Trends, Q1-2006 |
| Dose Ranging |
Targeting Trends, Q4-2005 |
| Saporin Safety |
Targeting Trends, Q3-2005 |
| Cytotoxicity of Unbound Saporin |
Targeting Trends, Q2-2005 |
| Effective Toxins |
Targeting Trends, Q4-2004 / Q1-2005 |
| Eliminating CBF Neurons |
Targeting Trends, Q3-2004 |
| Streptavidin versus Avidin |
Targeting Trends, Q2-2004 |
| Not the Right Stuff |
Targeting Trends, Q1-2004 |
| Dosing, Volume, and Animal Care |
Targeting Trends, Q3-2003 |
| Retrograde Transport |
Targeting Trends, Q2-2003 |
| Custom Peptide-Saporin Conjugates |
Targeting Trends, Q1-2003 |
| Custom Antibody-Saporin Conjugates |
Targeting Trends, Q4-2002 |
| Neuropeptide Toxins |
Targeting Trends, Q3-2002 |
| Toxin Safety |
Targeting Trends, Q1/Q2-2002 |
| Time Course of Targeted Toxins |
Targeting Trends, Q4-2001 |
| In Vivo Delivery of Targeted Toxins |
Targeting Trends Q3-2001 |
| Suicide Transport and Immunolesioning |
Targeting Trends Q2-2001 |
| In Vivo Use of Targeted Toxins |
Targeting Trends Q1-2001 |
| Second Immunotoxins |
Targeting Trends Q4-2000 |
ADVANCED
TARGETING SYSTEMS